DS
RPID icon

Daniel Sundheim’s Rapid Micro Biosystems RPID Stock Holding History

Daniel Sundheim’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,644,444
Closed -$18M – 27
2022
Q1 		$18M Hold
2,644,444
– – 0.21% 25
2021
Q4 		$28.1M Hold
2,644,444
– – 0.17% 40
2021
Q3 		$48.8M Buy
+2,644,444
New +$54.6M 0.27% 44

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Daniel Sundheim's RPID Position: Q2 2022 in Review

Daniel Sundheim sold out of Rapid Micro Biosystems (RPID) in Q2 2022, closing a stake of 2,644,444 shares — an estimated $18M sold.

Daniel Sundheim first reported a position in RPID in Q3 2021 and held it in 3 quarters. The position peaked at $48.8M in Q3 2021. 52 funds tracked by Wall St. Rank hold RPID as of Q2 2022.

  • Daniel Sundheim reported no remaining Rapid Micro Biosystems position as of Q2 2022 after selling out during the quarter.
  • Daniel Sundheim sold 2,644,444 Rapid Micro Biosystems shares in Q2 2022, an estimated $18M.
  • Daniel Sundheim first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 3 quarters.
  • Daniel Sundheim's Rapid Micro Biosystems position peaked at $48.8M in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2022.

Based on D1 Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.